Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings.

Published

Journal Article

In this paper, we provide recommendations on the management of cardiovascular disease (CVD) among patients with confirmed or suspected coronavirus disease (COVID-19) to facilitate the decision making of healthcare professionals in low resource settings. The emergence of novel coronavirus disease, also known as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions, leading to a pandemic. There is concern that COVID-19 is cardiotropic, and it interacts with the cardiovascular system on multiple levels. Individuals with established CVD are more susceptible to severe COVID-19. Through a consensus approach involving an international group this WHF statement summarizes the links between cardiovascular disease and COVID-19 and present some practical recommendations for the management of hypertension and diabetes, acute coronary syndrome, heart failure, rheumatic heart disease, Chagas disease, and myocardial injury for patients with COVID-19 in low-resource settings. This document is not a clinical guideline and it is not intended to replace national clinical guidelines or recommendations. Given the rapidly growing burden posed by COVID-19 illness and the associated severe prognostic implication of CVD involvement, further research is required to understand the potential mechanisms linking COVID-19 and CVD, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients.

Full Text

Duke Authors

Cited Authors

  • Prabhakaran, D; Perel, P; Roy, A; Singh, K; Raspail, L; Faria-Neto, JR; Gidding, SS; Ojji, D; Hakim, F; Newby, LK; Stępińska, J; Lam, CSP; Jobe, M; Kraus, S; Chuquiure-Valenzuela, E; Piñeiro, D; Khaw, K-T; Bahiru, E; Banerjee, A; Narula, J; Pinto, FJ; Wood, DA; Sliwa, K

Published Date

  • July 2020

Published In

Volume / Issue

  • 15 / 1

Start / End Page

  • 44 -

PubMed ID

  • 32923338

Pubmed Central ID

  • 32923338

Electronic International Standard Serial Number (EISSN)

  • 2211-8179

International Standard Serial Number (ISSN)

  • 2211-8160

Digital Object Identifier (DOI)

  • 10.5334/gh.823

Language

  • eng